Biodesix, Inc. announces it has entered into securities purchase agreements to issue 760,857 shares of its Series A Non-Voting Convertible Preferred Stock at a price of $46.00 per share for gross proceeds of $34,999,422 on April 5, 2024. Each share of Series A Non-Voting Convertible Preferred Stock will automatically convert to 40 shares of common stock for an aggregate of 30,434,280 shares of common stock. The transaction will include participation from certain members of management, certain of our directors and funds affiliated with these directors.

The transaction is expected to close on or about April 9, 2024. The transaction is subject to the stockholder approval.